19 October 2017
News and Views
Links and Services
fiogf49gjkf04A study published ahead of print in the Alimentary Pharmacology & Therapeutics examines the prognostic significance of fecal calprotectin in patients with inactive inflammatory bowel disease.
Fecal calprotectin, an established biomarker used to assess mucosal inflammation, has been shown
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors